We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
49 hedge funds and large institutions have $39.7M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
70% more call options, than puts
Call options by funds: $288K | Put options by funds: $169K
8% less funds holding
Funds holding: 53 → 49 (-4)
26% less capital invested
Capital invested by funds: $53.6M → $39.7M (-$13.9M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
4
Increased
6
Reduced
14
Closed
8
Calls
$288K
Puts
$169K
Net Calls
+$119K
Net Calls Change
+$229K
Top Buyers
| 1 |
PM
Prosight Management
Dallas,
Texas
|
+$883K |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
+$226K |
| 3 |
Morgan Stanley
New York
|
+$61.1K |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$17.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.8K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.32M |
| 2 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$1.07M |
| 3 |
Goldman Sachs
New York
|
-$590K |
| 4 |
Millennium Management
New York
|
-$351K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$227K |
